alprazolam has been researched along with Bladder Disorder, Neurogenic in 1 studies
Alprazolam: A triazolobenzodiazepine compound with antianxiety and sedative-hypnotic actions, that is efficacious in the treatment of PANIC DISORDERS, with or without AGORAPHOBIA, and in generalized ANXIETY DISORDERS. (From AMA Drug Evaluations Annual, 1994, p238)
alprazolam : A member of the class of triazolobenzodiazepines that is 4H-[1,2,4]triazolo[4,3-a][1,4]benzodiazepine carrying methyl, phenyl and chloro substituents at positions 1, 6 and 8 respectively. Alprazolam is only found in individuals that have taken this drug.
Excerpt | Relevance | Reference |
---|---|---|
" They represent an improvement compared with transdermal delivery by patches because they offer more dosage flexibility, less irritation potential and a better cosmetic appearance." | 2.43 | Pharmaceutical development and clinical effectiveness of a novel gel technology for transdermal drug delivery. ( Alberti, I; Carrara, DN; Grenier, A; Kraus, H, 2005) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Alberti, I | 1 |
Grenier, A | 1 |
Kraus, H | 1 |
Carrara, DN | 1 |
1 review available for alprazolam and Bladder Disorder, Neurogenic
Article | Year |
---|---|
Pharmaceutical development and clinical effectiveness of a novel gel technology for transdermal drug delivery.
Topics: Administration, Cutaneous; Alprazolam; Animals; Anti-Anxiety Agents; Drug Delivery Systems; Estradio | 2005 |